Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant
Kasama Manothummetha, Nipat Chuleerarux, Anawin Sanguankeo, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e226822-e226822
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Remdesivir Resistance in Transplant Recipients With Persistent Coronavirus Disease 2019
John I Hogan, Ralf Duerr, Dacia Dimartino, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 2, pp. 342-345
Open Access | Times Cited: 78
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients
Delphine Kemlin, Nicolas Gemander, Stéphanie Depickère, et al.
American Journal of Transplantation (2023) Vol. 23, Iss. 5, pp. 649-658
Open Access | Times Cited: 24
Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST Cohort
Cecilia Bonazzetti, Beatrice Tazza, Dino Gibertoni, et al.
Clinical Infectious Diseases (2023) Vol. 76, Iss. 10, pp. 1761-1767
Open Access | Times Cited: 21
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study
Wilhelmine Meeraus, Mark Joy, Mario Ouwens, et al.
Journal of Infection (2024) Vol. 88, Iss. 4, pp. 106129-106129
Open Access | Times Cited: 7
Excess mortality in COVID-19-affected solid organ transplant recipients across the pandemic
Shigeyoshi Yamanaga, Keita Shimata, Satoko Ohfuji, et al.
American Journal of Transplantation (2024) Vol. 24, Iss. 8, pp. 1495-1508
Open Access | Times Cited: 7
Vaccination for the Prevention of Infection among Immunocompromised Patients: A Concise Review of Recent Systematic Reviews
Kay Choong See
Vaccines (2022) Vol. 10, Iss. 5, pp. 800-800
Open Access | Times Cited: 33
Factors Associated With COVID-19 Vaccine Response in Transplant Recipients: A Systematic Review and Meta-analysis
Jiajing Li, Ibrahim Ayada, Yining Wang, et al.
Transplantation (2022) Vol. 106, Iss. 10, pp. 2068-2075
Open Access | Times Cited: 32
Monoclonal Antibodies in Prevention and Early Treatment of COVID-19 in Lung Transplant Recipients: A Systematic Review and Perspective on the Role of Monoclonal Antibodies in the Future
David A. Van Eijndhoven, Robin Vos, Saskia Bos
Transplant International (2025) Vol. 38
Open Access
ORCHESTRA Delphi Consensus: Diagnostic and Therapeutic Management of SARS-CoV-2 Infection in Solid Organ Transplant Recipients
Beatrice Tazza, Natascia Caroccia, Alice Toschi, et al.
Clinical Microbiology and Infection (2025)
Closed Access
Clinical outcomes in immunocompromised adults with COVID-19, based on anti-spike IgG serostatus and monoclonal antibody therapy: a retrospective cohort study in the Omicron period
Shilpa Vasishta, Judith A. Aberg, Gopi Patel, et al.
Therapeutic Advances in Infectious Disease (2025) Vol. 12
Open Access
Persistent SARS-CoV-2–specific immune defects in kidney transplant recipients following third mRNA vaccine dose
William A. Werbel, Andrew H. Karaba, Teresa Po‐Yu Chiang, et al.
American Journal of Transplantation (2023) Vol. 23, Iss. 6, pp. 744-758
Open Access | Times Cited: 14
Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study
Dima Kabbani, Demitra M Yotis, Victor H. Ferreira, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 5
Open Access | Times Cited: 12
SARS‐CoV‐2 vaccine antibody response and breakthrough infections in transplant recipients
Benedict Vanlerberghe, Casper Vrij, Kris Bogaerts, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 12
Humoral and T-cell response 12 months after the first BNT162b2 vaccination in solid organ transplant recipients and controls: Kinetics, associated factors, and role of SARS-CoV-2 infection
Omid Rezahosseini, Sebastian Rask Hamm, Line Dam Heftdal, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 11
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients
Matthias Becker, Anne Cossmann, Karsten Lürken, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Torque teno virus viral load predicts SARS‐CoV‐2 vaccine response in kidney transplant recipients
Morgane Solis, Iliès Benotmane, Floriane Gallais, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 7
Closed Access | Times Cited: 9
Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination
Marlou J. Jongkees, Daryl Geers, Kathryn S. Hensley, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 5, pp. 651-662
Open Access | Times Cited: 12
COVID-19 Vaccines—All You Want to Know
Akira Shishido, Ashley H. Barnes, Shivakumar Narayanan, et al.
Seminars in Respiratory and Critical Care Medicine (2023) Vol. 44, Iss. 01, pp. 143-172
Closed Access | Times Cited: 7
Cellular and humoral immune responses after a third dose of SARS-CoV-2 mRNA vaccine in lung transplant recipients in Japan
Masahiro Ui, Takashi Hirama, Miki Akiba, et al.
Vaccine (2023) Vol. 41, Iss. 31, pp. 4534-4540
Open Access | Times Cited: 7
Outcomes of COVID‐19–Positive Donor Heart Transplantation in the United States
Samuel T. Kim, Amit Iyengar, Mark R. Helmers, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 14
Open Access | Times Cited: 7
SARS-CoV-2 Vaccination in Solid-Organ Transplant Recipients
Maddalena Peghin, Elena Graziano, Paolo Grossi
Vaccines (2022) Vol. 10, Iss. 9, pp. 1430-1430
Open Access | Times Cited: 11
Mycophenolic Acid Exposure Determines Antibody Formation Following SARS‐CoV‐2 Vaccination in Kidney Transplant Recipients: A Nested Cohort Study
Soufian Meziyerh, Pim Bouwmans, Teun van Gelder, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 114, Iss. 1, pp. 118-126
Open Access | Times Cited: 6
Effectiveness of vaccination against SARS-CoV-2 and the need for alternative preventative approaches in immunocompromised individuals: a narrative review of systematic reviews
Thuan Tong Tan, Heng Joo Ng, Barnaby Edward Young, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 341-365
Open Access | Times Cited: 6
Protective Effect of Vaccine Doses and Antibody Titers Against SARS-CoV-2 Infection in Kidney Transplant Recipients
Chien‐Chia Chen, Meng-Kai Hsu, Yi‐Jen Huang, et al.
Transplant International (2023) Vol. 36
Open Access | Times Cited: 6
Cellular immune response of SARS-CoV-2 vaccination in kidney transplant recipients: a systematic review and meta-analysis
Suwasin Udomkarnjananun, Sivaporn Gatechompol, Asada Leelahavanichkul, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top